Is Sunesis Pharmaceuticals (SNSS) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 07/23/20
Sunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/10/20
Is Sunesis Pharmaceuticals (SNSS) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 03/17/20
Sunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/10/20
Sunesis Pharmaceuticals Announces Data from Ongoing Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell MalignanciesGlobeNewsWire • 12/05/19
Sunesis Pharmaceuticals, Inc. (SNSS) Management on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/13/19
Sunesis Pharmaceuticals to Present at 28th Annual Credit Suisse Healthcare ConferenceGlobeNewsWire • 11/08/19
Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsGlobeNewsWire • 10/16/19
Sunesis Pharmaceuticals, Inc. (SNSS) Shares March Higher, Can It Continue?Zacks Investment Research • 09/05/19
Sunesis Pharmaceuticals, Inc. (SNSS) Interim CEO Dayton Misfeldt on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/08/19
Sunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q1 20189 Results - Earnings Call TranscriptSeeking Alpha • 05/08/19